Clinical Trials Logo

Lung Cancer clinical trials

View clinical trials related to Lung Cancer.

Filter by:

NCT ID: NCT02695680 Terminated - Lung Cancer Clinical Trials

Lung SBRT Motion Management (GCC 1619)

Start date: October 27, 2017
Phase:
Study type: Observational

Real-time optical surface monitoring data will be acquired from 44 human patients with primary or metastatic lung lesions during and after their 4DCT scan (standard-of-care at our institution). A patient-specific 4D model will be developed using the raw 4DCT projections time-correlated with real-time surface monitoring. In addition, before delivering each dose fraction (3 - 5 for lung SBRT), we will acquire three 15s kV fluoroscopic image acquisitions, time-correlated with optical surface monitoring. The acquisitions will be distributed over three well-spaced beam angles, e.g., every 4th angle for a 12-field plan.

NCT ID: NCT02694380 Terminated - Breast Cancer Clinical Trials

Measuring the Effect of Radiation Therapy on Patient Activity Levels

Start date: July 2015
Phase:
Study type: Observational

The goal of this study is to measure the effect of radiation therapy on the activity levels of patients. This will be achieved by tracking their activity levels during a treatment course of radiation therapy.

NCT ID: NCT02687997 Completed - Lung Cancer Clinical Trials

Prevalence of Sleep Disordered Breathing in a Lung Cancer Screening Cohort

SAILS
Start date: February 2016
Phase: N/A
Study type: Interventional

Prospective study of sleep disordered breathing in a lung cancer screening cohort.

NCT ID: NCT02686775 Recruiting - Lung Cancer Clinical Trials

The PACO Project: A Clinical Study of a PAtient COach Program in Vulnerable Lung Cancer Patients

PACO
Start date: January 2016
Phase: N/A
Study type: Interventional

The randomized trial evaluates whether assigning a patient coach to vulnerable lung cancer patients will empower these patients to participate in the treatment decision process, help patients navigate the health care system while undergoing treatment and adhere to cancer treatment and to recommendations for supportive care. Half of the participants will receive standard care and be offered a patient coach while the other half will receive standard care.

NCT ID: NCT02679872 Completed - Lung Cancer Clinical Trials

Video-assisted Thoracoscopic Surgery Teams' Perception of Non-technical Skills

Start date: February 2016
Phase: N/A
Study type: Observational

Good non-technical skills (NTS) have been shown to prevent adverse events and errors. Improvements of NTS can be achieved by simulation based-team training.The NTS of the operating theatre team performing video-assisted thoracoscopic surgery (VATS) is speculated to differ fra open thoracic surgery, as is the case with technical skills; however, these have not been investigated. The aim of this study is to explore which NTS the members of the VATS team perceive to be most important to patient care and safety. Exploration will be done through a deductive, qualitative analysis of semi-structured group and individual interviews with VATS team members. A theoretical perspective of Hollnagels Safety-II will be taken using the taxonomy of Oxford Non-Technical Skills (NOTECHS) system with the aim of informing patient safety.

NCT ID: NCT02676050 Terminated - Lung Cancer Clinical Trials

Visualising c-MET and Activated Neutrophils in Lung Cancer

DUAL
Start date: October 4, 2019
Phase: Early Phase 1
Study type: Interventional

Lung cancer is currently a major health problem in the UK. Despite being one of the most common cancers, lung cancer has a poor prognosis compared to other types of cancer and is the leading cause of cancer death in the world. As opposed to other organs, the lung is highly susceptible to inflammatory insults, for example from bacterial infection-induced and tobacco-induced inflammation. It has long been known that the cellular microenvironment that nurtures tumour growth and development is linked to sites of chronic inflammation but molecular insights into how external inflammation boosts or inhibits cancer in the lungs remains unclear. This study aims to directly visualise the expression of a well known marker of cancerous tissue, c-MET, and the activity of neutrophils in human lung cancer in vivo in situ using fibre-based endomicroscopy.

NCT ID: NCT02675842 Withdrawn - Lung Cancer Clinical Trials

Investigation of Cannabis for Pain and Inflammation in Lung Cancer

Start date: n/a
Phase: Phase 1
Study type: Interventional

Radiation therapy to the chest is used in late stage lung cancer, and it often leads to inflammation of the esophagus. The inflammation is expected to occur in about 75% of patient, and usually begin within a week of starting radiation therapy. The esophagitis causes pain and difficulty eating. It can also result in stopping or delaying treatment.Radiation therapy to the chest is used in late stage lung cancer, and it often leads to inflammation of the esophagus. The inflammation is expected to occur in about 75% of patient, and usually begin within a week of starting radiation therapy. The esophagitis causes pain and difficulty eating. The endocannabinoid system is prominent in the gastrointestinal system, and cannabis has been shown to greatly inhibit inflammation. The compound (-)-trans-Δ9-tetrahydrocannabinol (Δ-9-THC) has effects that reduce inflammation and pain. Cannabidiol is a component of cannabis that does not produce subjective or intoxicating effects, but also has prominent anti-inflammatory properties. The goal of this study is to perform a double-blind, placebo-controlled study to investigate the efficacy of cannabis, compared to placebo, in participants undergoing RT (Radiation Therapy) for lung cancer. Cannabis that has a high concentration of cannabidiol will be used , which is a cannabinoid that does not change perception or produce intoxication, and low in Δ-9-THC. In this way, the hope is to maximize the benefit of cannabis, while lowering the possible side effects of cannabis in medically ill participants.

NCT ID: NCT02675829 Recruiting - Lung Cancer Clinical Trials

Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers

Start date: February 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to find out what effects, a drug called ado-trastuzumab emtansine has on the patient and their cancer which is thought to be controlled by the abnormal HER2 gene.

NCT ID: NCT02673021 Terminated - Lung Cancer Clinical Trials

MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)

MARK 1A
Start date: June 8, 2016
Phase: N/A
Study type: Interventional

Does lung ablation improve clinical outcomes for patients deemed to be surgically high-risk?

NCT ID: NCT02665390 Not yet recruiting - Lung Cancer Clinical Trials

Percutaneous Cryoablation Peripheral Lung Cancer

PCPLC
Start date: February 2016
Phase: N/A
Study type: Interventional

This study is focus on percutaneous cryoablation,which was for the treatment of medically inoperable Peripheral lung cancer.The patients who were agreed to attend the study will accept the operation. After the operations,they will follow up according to the plan.